COMPANY NEWS

Back to homepage
COMPANY NEWS NEWS

MedTech start-up, Axis Spine Technologies, completes £2.2m funding round led by ACF Investors

Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from Mercia’s EIS funds. Mercia was the first investor when Axis

COMPANY NEWS NEWS PRODUCT NEWS

Sacrix develops new iteration of SacroFuse for sacroiliac joint support

Sacrix has developed the third iteration of the SacroFuse threaded compression device for immediate stabilisation of the sacroiliac joint for pain relief and ultimately fusion

COMPANY NEWS

RABEA by SIGNUS – gold standard in anterior cervical fusion

Promotional feature   RABEA® SIGNUS developed the first plan-parallel fusion cage worldwide. RABEA® received CE approval in 1996 and is, more than 25 years later, still gold standard in anterior

COMPANY NEWS

BIG ST – ONE design, many options

Promotional feature   BIG ST – ONE Design – many options With the BIG ® ST ALIF Cage, SIGNUS expands their ST (Structural Titanium) product portfolio of 3D printed cages.

COMPANY NEWS

ST-Line – Next in fusion

Promotional feature With its new ST-Line, SIGNUS has applied the progress from endoprosthetic research to spinal surgery Regardless of the application, the excellent mechanical and biological properties of titanium and

COMPANY NEWS

Success of first JASPIS ST® surgery in Australia

Neurosurgeon Dr Andrew Miles, Neurospine Institute, Western Australia successfully completed the first JASPIS® ST surgery in Australia. Dr Miles’ first JASPIS ST case was a patient with degenerative disc disease

COMPANY NEWS

More appealing, more informative and with new functions: the revised SIGNUS website is online

Since the end of August SIGNUS presents itself with a new website. The new online presence offers clearly arranged and comprehensive information about the family business SIGNUS, its products and

COMPANY NEWS

Results of the largest independent randomised controlled trial of a digital therapy against chronic pain

In the largest independent randomised controlled trial (RCT) of its type, a multimodal app-based digital therapy programme for patients with non-specific low back pain has outperformed standard-of-care treatment across all

COMPANY NEWS

Biocomposites signs new exclusive distributor in Australia

Biocomposites, an international medical devices company that engineers, manufactures and markets products for use in infection management in bone and soft tissue, recently announced that it has signed an exclusive

COMPANY NEWS NEWS

DePuy Synthes extends partnership with AO

DePuy Synthes will continue to work with the AO Foundation to deliver professional education and develop innovations that help improve patient outcomes and increase efficiency of care, after renewing their